Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: European Region
  • Asset Class: Equity
  • Geographic Focus: European Region

JPMorgan Funds - Europe Research Enhanced Index Equity Fund

+ Add to Watchlist

JPEREIX:LX

198.27 EUR 1.47 0.74%

As of 00:59:30 ET on 05/29/2015.

Snapshot for JPMorgan Funds - Europe Research Enhanced Index Equity Fund (JPEREIX)

Year To Date: +20.72% 3-Month: +5.36% 3-Year: +22.21% 52-Week Range: 148.55 - 201.29
1-Month: +1.04% 1-Year: +21.64% 5-Year: - Beta vs LUXXX: 0.81

Mutual Fund Chart for JPEREIX

No chart data available.
  • JPEREIX:LX 198.27
  • 1M
  • 1Y
Interactive JPEREIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for JPEREIX

JPMorgan Funds - Europe Research Enhanced Index Equity Fund is a SICAV incorporated in Luxembourg. The Fund's objective is long-term return. The Fund invests at least 67% of its total assets in equity and equity-linked securities of companies that are incorporated under the laws of, and have their registered office in a European country, or derive their economic activity from Europe.

Inception Date: 09-08-2011 Telephone: 352-34-10-101 Tel
Managers: DEMETRIS GEORGHIOU / IDO EISENBERG
Web Site: www.jpmorganassetmanagement.com

Fundamentals for JPEREIX

NAV (on 2015-05-29) 198.27
Assets (M) (on 2015-05-29) 87.21
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for JPEREIX

No dividends reported

Fees & Expenses for JPEREIX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 0.15

Top Fund Holdings for JPEREIX

Filing Date: 04/30/2015
Name Position Value % of Total
Nestle SA 42,736 2,967,542 3.425%
Roche Holding AG 9,740 2,499,379 2.885%
Novartis AG 24,738 2,277,414 2.628%
Royal Dutch Shell PLC 62,536 1,766,298 2.039%
Sanofi 17,660 1,610,592 1.859%
HSBC Holdings PLC 181,163 1,610,214 1.858%
British American Tobacco PLC 30,606 1,549,484 1.788%
Bayer AG 11,576 1,503,722 1.735%
BP PLC 232,448 1,498,608 1.730%
Vodafone Group PLC 420,244 1,328,736 1.534%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil